Pfizer Inc (PFE)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 88,203,000 | 89,014,000 | 95,661,000 | 77,201,000 | 63,238,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $88,203,000K
= 0.00
The debt-to-equity ratio for Pfizer Inc remained consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that Pfizer has not utilized debt as a significant source of financing relative to equity during this period. A debt-to-equity ratio of 0.00 means that the company has no debt or very minimal debt in relation to its equity. This suggests that Pfizer has a strong financial position with a low risk of financial distress related to excessive debt levels. It also implies that the company may rely more on equity financing, which can be viewed positively by investors and creditors as it indicates a lower level of financial leverage. Overall, the consistent 0.00 debt-to-equity ratio over the 5-year period reflects Pfizer's conservative financial management approach regarding debt usage.
Peer comparison
Dec 31, 2024